Mometasone Furoate Ointment USP
Recall D-1286-2015, part of FDA recall event 71765. See Perrigo Israel Pharmaceuticals's company page.
Perrigo Israel Pharmaceuticals started this Class III drug recall on Jul 13, 2015 (voluntary: firm initiated); FDA lists it as terminated, terminated Feb 11, 2016.
- Classification: Class III
- Started: Jul 13, 2015
- Status: Terminated
Subpotent drug
- Product
- Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, Israel, Distributed by Perrigo, Allegan, MI 49010, NDC 45802-0119-37
- Quantity
- 158,268 tubes
- Lots and codes
- Lot # 063630, Exp 04/16; 069793, Exp 11/16; 071745, Exp 02/17; 076150, Exp 07/17; 081317, Exp 12/17
- Distribution
- Nationwide and Puerto Rico
- Recalling firm
- Perrigo Israel Pharmaceuticals, Yeruham, N/A, Israel
- How the firm notified
- Letter
- FDA classified
- Aug 5, 2015
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports